Atlas Trials

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam

Clinical trial NCT03367559 · UNKNOWN

Trial details

NCT number
NCT03367559
Sponsor
Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Rotavirus Infections
Start date
2018-02-08
Primary completion
2019-05-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.